Replies to post #80640 on Ayala Pharmaceuticals Inc (ADXS)

[DewDiligence]

Many small biotech companies forgo quarterly conference calls.

[Batermere]

It’s probably good that KB doesn’t flap his jaw during a CC with him having the IQ of a brain dead amoeba. The “King of BK” is right on schedule doing the same thing to ADXS as he did to ROSG. He’s one of Sidransky’s good ol’ boy GOFERS, willing to do whatever THE RAT wants that will line his slimy, greedy, filthy pockets. Pathetic and disgusting.

[fbg0316]

I see it as a positive sign that they aren't doing a conference call and there was no mention of AXAL in the press release, which could mean they are closing in on a deal on AXAL and can't say anything about it either way at this point.

Berlin inherited a mess of a company but he has shown resolve in righting the company's misguided business strategy and reducing the reckless cash burn of the last five years. Most importantly, unlike Dan O'Connor the liar, Berlin is honest and ethical and aligned with us. O'Connor burnt investor trust, and we are paying for it now as evidenced by the terrible terms of these last two raises. This recent quarterly report though shows Berlin's focus and promise as a real CEO. IMO he will rebuild the trust O'Connor lost and hopefully with some kind of deal on AXAL and a monetary deal on HOT we will be back up to a fairer valuation in the coming months.